Early hydroxychloroquine macular toxicity

Arthritis Rheum. 2001 Aug;44(8):1959-61. doi: 10.1002/1529-0131(200108)44:8<1959::AID-ART334>3.0.CO;2-A.


This report describes the case of an appropriately dosed patient who developed maculopathy <8 years after starting hydroxychloroquine (HCQ) therapy for systemic lupus erythematosus. Risk factors and screening for HCQ-associated maculopathy are discussed.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Female
  • Humans
  • Hydroxychloroquine / adverse effects*
  • Hydroxychloroquine / therapeutic use
  • Lupus Erythematosus, Systemic / drug therapy
  • Macular Degeneration / chemically induced*


  • Hydroxychloroquine